The CDD’s first mission is to vigorously engage in research aimed at the discovery of therapeutic agents.
The second mission will be to develop research and educational interactions with the pharmaceutical and biotechnological industries within Massachusetts, and also serve as a resource for novel start-up biopharmaceutical industries.
The CDD’s third mission encompasses a unique educational component centered around “Drug Discovery” as an area of concentration that will educate new scientists in this multidisciplinary field. In support of our mission, the National Institute on Drug Abuse has awarded a five year, multimillion dollar grant to Dr. Makriyannis as Principal Investigator for the training (predoctoral and postdoctoral levels) of future scientists in the field of Medications Development for Drugs of Abuse. The Center will coordinate educational activities for both students and the general public in special areas of disease and therapeutics.
George D. Behrakis Endowed Chair in Pharmaceutical Biotechnology
The above core facility will be maintained under the auspices of the CDD and will serve to: